ManRos Therapeutics(製薬企業):製品開発パイプライン動向2014

◆英語タイトル:ManRos Therapeutics - Product Pipeline Review - 2014
◆発行会社(リサーチ会社):Global Markets Direct
Single UserUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Site LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide (Global Site License)USD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はGlobal Markets Direct社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Global Markets Direct社の概要はこちらでご確認いただけます。


ManRos Therapeutics – Product Pipeline Review – 2014


Global Markets Direct’s, ‘ManRos Therapeutics – Product Pipeline Review – 2014’, provides an overview of the ManRos Therapeutics’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ManRos Therapeutics’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of ManRos Therapeutics including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of ManRos Therapeutics’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the ManRos Therapeutics’s pipeline products

Reasons to buy

- Evaluate ManRos Therapeutics’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of ManRos Therapeutics in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the ManRos Therapeutics’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of ManRos Therapeutics and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of ManRos Therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of ManRos Therapeutics and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues


Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
ManRos Therapeutics Snapshot 4
ManRos Therapeutics Overview 4
Key Information 4
Key Facts 4
ManRos Therapeutics – Research and Development Overview 5
Key Therapeutic Areas 5
ManRos Therapeutics – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
ManRos Therapeutics – Pipeline Products Glance 9
ManRos Therapeutics – Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
ManRos Therapeutics – Drug Profiles 11
Small Molecule to Inhibit CKD for Polycystic Kidney Disease 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Aftins 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Small Molecule To Inhibit Casein Kinase 1, Cyclin-Dependent Kinases, Glycogen Synthase Kinase 3 For Alzheimers disease 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecule to Inhibit Protein Kinase for Cancer 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ManRos Therapeutics – Pipeline Analysis 15
ManRos Therapeutics – Pipeline Products by Target 15
ManRos Therapeutics – Pipeline Products by Molecule Type 16
ManRos Therapeutics – Pipeline Products by Mechanism of Action 17
ManRos Therapeutics – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20

List of Tables
ManRos Therapeutics, Key Information 4
ManRos Therapeutics, Key Facts 4
ManRos Therapeutics - Pipeline by Indication, 2014 6
ManRos Therapeutics - Pipeline by Stage of Development, 2014 7
ManRos Therapeutics - Monotherapy Products in Pipeline, 2014 8
ManRos Therapeutics - Preclinical, 2014 9
ManRos Therapeutics - Discovery, 2014 10
ManRos Therapeutics - Pipeline by Target, 2014 15
ManRos Therapeutics - Pipeline by Molecule Type, 2014 16
ManRos Therapeutics - Pipeline Products by Mechanism of Action, 2014 17

List of Figures
ManRos Therapeutics - Pipeline by Top 10 Indication, 2014 6
ManRos Therapeutics - Pipeline by Stage of Development, 2014 7
ManRos Therapeutics - Monotherapy Products in Pipeline, 2014 8
ManRos Therapeutics - Pipeline by Top 10 Target, 2014 15
ManRos Therapeutics - Pipeline by Top 10 Molecule Type, 2014 16
ManRos Therapeutics - Pipeline Products by Top 10 Mechanism of Action, 2014 17


★医療情報レポート[ManRos Therapeutics(製薬企業):製品開発パイプライン動向2014]についてメールでお問い合わせはこちら